Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients

NCT ID: NCT01321866

Last Updated: 2016-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate and compare the primary patency rate at 12 months in a group of hemodialysis patients operated on by cutting balloon and in a group of hemodialysis patients operated by conventional balloon.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteriovenous Fistula Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental arm

Patients in this arm will have angioplasty of a fistula stenosis using a cutting balloon

Group Type EXPERIMENTAL

Cutting balloon angioplasty

Intervention Type PROCEDURE

Angioplasty of fistula stenosis using a cutting balloon

Standard arm

Patients in this arm will have angioplasty of a fistula stenosis using a non-cutting balloon.

Group Type ACTIVE_COMPARATOR

Angioplasty

Intervention Type PROCEDURE

Angioplasty of fistula stenosis using a non-cutting balloon

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cutting balloon angioplasty

Angioplasty of fistula stenosis using a cutting balloon

Intervention Type PROCEDURE

Angioplasty

Angioplasty of fistula stenosis using a non-cutting balloon

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 12 months of follow-up
* The patient is on hemodialysis because of chronic renal insufficiency
* The patient's vascular access is an arterio-venous fistula
* The patient has a venous stenosis in the fistula (first event in the studied zone)
* The patient is scheduled for angioplasty

Exclusion Criteria

* The patient is participating in another study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The patient cannot fluently read French
* The patient cannot understand French
* The patient is pregnant
* The patient is breastfeeding
* Short term dialysis
* The vascular access is a "graft"
* The stenosis in question is a recurrence, and not a first event in the studied zone
* The life expectancy of the patient is \< 12 months
* Medical emergency situation
* Peritoneal dialysis
* At-home dialysis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric Picard, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Nîmes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire de Nîmes

Nîmes, Gard, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-A00332-39

Identifier Type: OTHER

Identifier Source: secondary_id

AOI/2010/EP-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.